In addition, the expression of CAP1 in tumor tissues was significantly associated with a tumor, lymph node metastasis, and TNM stage in NSCLC patients; CAP1 was highly expressed in lung cancer with brain metastasis as compared to other metastatic groups (bone metastasis and visceral metastasis). This evidence concerns the gene CAP1 and neoplasm.